Features of Parapneumonic Effusions

1. Light RW Parapneumonic effusions and empiema Proc Am Thorac Soc. 2006; 3(1): 75-80.10.1513/pats.200510-113JHSearch in Google Scholar

2. Hasley PB, Albaum MN, Li Y-H, et all. Do pulmonary radiographic findings at presentation predict mortality in patients with community acquired pneumonia? Arch Intern Med 1996; 156: 2206-2212.10.1001/archinte.156.19.2206Search in Google Scholar

3. Girdhar A., Shujaat A, Bajwa A. Management of infectious processes of the pleural space: a review, Pulmonary Medicine 2012; 2012(2012), Article ID 816502, p. 10.Search in Google Scholar

4. Light RW. Pleural diseases, 4th ed Baltimore:Lippincott, Williams and Wilkins; 2001; Virology 2001; 289: 6-14.Search in Google Scholar

5. Chapman SJ, Davies RJO The management of pleural space infection Respitology 2004; 9: 4-11.10.1111/j.1440-1843.2003.00535.xSearch in Google Scholar

6. Mc Cauley L, Dean N. Pneumonia and empiema: causal, causal or unknown J thorac Dis 2015; 7(6): 992-998.Search in Google Scholar

7. Finich S., Chalmers J.D. Parapneumonic effusions: epidemiology and predictors of pleural infection Curr Respir Care Rep 2014; 3: 52-60.10.1007/s13665-014-0074-4Search in Google Scholar

8. Koegelenberg C.F.N., Diacon A.H, Bolliger C.T. Parapneumonic pleural effusion and empyema Respiration 2008; 75: 241-250.10.1159/000117172Search in Google Scholar

9. Smith JA, Mulleroworth MH, Westlake GW, et al. Empyema thoracis: 14-year expirience in a teaching center. Ann Thorac Surg 1991; 51: 39-42.10.1016/0003-4975(91)90443-TOpen DOISearch in Google Scholar

10. Medford AR, Maskell N. Pleural effusion. Post-grad Med J 2005; 81: 702e10.10.1136/pgmj.2005.035352Search in Google Scholar

11. Suarez PR, Gilart JF, PerezJMH et al. Treatment of complicated parapneumonical pleural effusion and pleural parapneumonic empiema Med Sci Monit, 2012; 18(7): CR 443-449.10.12659/MSM.883212Search in Google Scholar

12. Djuric M, Djuric D, Culibrk T, Povazan DJ Parapneumonic effusions: Feautres, diagnostics and treatment options. Srp Arh Celok Lek 2014; 142(11-12): 680-687.10.2298/SARH1412680DSearch in Google Scholar

13. Pocrel JM, Light RW Diagnostic approach to pleural effusion in adults Am Fam Physician. 2006 Apr 1; 73(7): 1211-20.Search in Google Scholar

14. Davis HE, Davies RJO, Davies CWH. Management of pleural infection in adults: British Trocracis Society pleural disease guideline 2010 Thorax. 2010; 65(Suppl 2): 41-53.10.1136/thx.2010.137000Search in Google Scholar

15. Light RW, Rodriguez RM. Management of parapneumonic effusions Clin Chest Med. 1998 Jun; 19(2): 373-82.10.1016/S0272-5231(05)70084-8Search in Google Scholar

16. Daniil Z.D, Zntzaras E, KIropulus T. et al. Discrimination of exudative pleural effusion based on multiple biological parametars Eur Respir J 2007; 36: 957-964.10.1183/09031936.0012630617690119Open DOISearch in Google Scholar

17. Ozol D, Oktem S, Erdinc E. Complicated parapneumonic effusion and empyema thoracis: microbiologic and therapeutic aspects. Respir Med.2006; 100: 286-91.10.1016/j.rmed.2005.05.01815998584Search in Google Scholar

18. Tsang KY, Leung WS, Chan VL, Lin AW, Chu CM. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcome. Hong Kong Med. 2010; 16(4): 357-61.Search in Google Scholar

19. Chalmers JD, Singanayagam A, Murray MP, et all. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009 Jul; 64(7): 592-7.10.1136/thx.2008.105080Open DOISearch in Google Scholar

20. Castro DJ, Diaz G, Perez-Rodrigez E, Light RW. Prognostic features of residual thickening in parapneumonic pleural effusions Eur Respir J 2003; 21: 952-955.10.1183/09031936.03.00099502Open DOISearch in Google Scholar

21. Falguera M, Carratalà J, Bielsa S, et all. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011 Nov; 38(5): 1173-9.10.1183/09031936.00000211Search in Google Scholar

22. MCGrath EE Anderson PB. Diagnosis of pleural effusion: A systematic approach American Journal of Critical Care 2011; 20: 119-128.10.4037/ajcc2011685Open DOISearch in Google Scholar

23. Light RW. Management of parapneumonic effusions Egyp Jour of Bronch 2008; 2: 208-212.Search in Google Scholar

24. Shirakabe A, Hata N, Yokoyama Sh. Cytokine levels in pleural effusions of patients under intensive care. Journal of Nippon Medical School 2008; 75(5): 262-26.10.1272/jnms.75.262Search in Google Scholar

25. Brims FJH, Lansley SM, Vaterer GW, Lee YCG. Empyema thoracis: new insights into an old disease. Eur Respir Rev 2010; 19: 117, 220-228.10.1183/09059180.00005610Search in Google Scholar

26. Yang P-C, Luh K-T, Chang D-B et al. Value of sonography in determining the nature of pleural effusion: Analysis of 320 cases AJR Am J Roentgenol. 1992 Jul; 159(1): 29-33.10.2214/ajr.159.1.1609716Search in Google Scholar

27. Tsai T-H, Yang P-C Ultrasound in the diagnosis and management of pleural disease Curr Opin Pulm Med. 2003; 9(4).10.1097/00063198-200307000-00007Search in Google Scholar

28. Chin NK Lim TK. Treatment of complicated parapneumonic effusion and pleural empyema: A four-year prospective study. Singapore Med J 1996; 37: 631-635.Search in Google Scholar

29. Vaziri M, Abed O. Managenet of thoracic empyema: Review of 112 cases. Acta Medica Iranica, 2012; 50(3): 203-207.Search in Google Scholar

30. Garrido VV, Sancho JF, Blasco H et al. Diagnosis and treatment of leural effsion. Arch Bronconeumol. 2006; 42(7): 349-72.10.1016/S1579-2129(06)60545-4Open DOISearch in Google Scholar

31. Porcel JM, Galindo C, Esquerda A et al. Pleural fluid interleukin-8 and C reactive protein for discrimiating complicated non-purulent from uncomplicatd parapneumonic effusions. Respirology. 2008; 13: 58-62.10.1111/j.1440-1843.2007.01189.x18197912Search in Google Scholar